Within a recent study, we described the identification plus the characterization of a completely new atypical opioid receptor with distinctive adverse regulatory Houses in the direction of opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a https://mickd369urm9.prublogger.com/profile